Loading company…
Pathalys Pharma develops treatments for patients with end-stage renal disease.
Founded in 2021 and based in North Carolina, Pathalys Pharma develops treatments for end-stage renal disease, including calcimimetics for secondary hyperparathyroidism. In January 2023, it raised venture funding led by Abingworth, with Carlyle Group, OrbiMed Advisors, Catalys Pacific and DaVita Venture Group participating. The round was part of a larger USD 150 million equity and debt financing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in